The global single-cell genome sequencing market is projected to grow significantly in the coming years. Rising occurrence of chronic & immune system syndrome and cancer, growing R&D activities, and increasing focus by the key companies on product expansion are amongst the key developments propelling the market expansion.
Global Single-Cell Genome Sequencing Market: Overview
Single-cell genome sequencing is a technique that is used to study the sequence data with upsurge next-generation sequencing expertise from a cell. This method has come up as a potent instrument that aims to offer intelligence and understanding of genetics by bringing the analysis of genomes to the cellular stage. Single-cell genome sequencing technique has an extensive impact on several diverse fields of biology comprising cancer research, immunology microbiology, tissue mosaicism, and neurobiology.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2022 |
Historic Years | 2018 - 2022 |
Forecast Years | 2023 - 2030 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2023 to 2030 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Global Single-Cell Genome Sequencing Market: Growth Factors
The global single-cell genome sequencing market is projected to grow significantly in the coming years. Rising occurrence of chronic & immune system syndrome and cancer, growing R&D activities, and increasing focus on the key companies on product expansion are amongst the key developments propelling the market expansion. Furthermore, supportive government regulations are projected to propel the development of the global single-cell genome sequencing market in the coming years.
Technological developments in the division of single-cell genome sequencing are likely to play an active role in the expansion of the global single-cell genome sequencing market. The technologically developed platforms offer perceptive analysis software solutions and are cost efficient in nature.
Global Single-Cell Genome Sequencing Market: Segmentation
The global single-cell genome sequencing market is classified into technology, product, disease area, workflow, end-user, and application. In terms of product, the global single-cell genome sequencing market is bifurcated into reagents and instruments. In terms of technology, the global single-cell genome sequencing market is fragmented into PCR, NGS, qPCR, MDA, and microarray. In terms of workflow, the global single-cell genome sequencing market is categorized into sample preparation, genomic analysis, single cell isolation, and sample preparation. In terms of disease area, the global single-cell genome sequencing market is fragmented into microbiology, neurobiology, prenatal diagnosis, cancer, immunology, and others. In terms of end-user, the global single-cell genome sequencing market is divided into clinics, academic and research laboratories, biotechnology and biopharmaceutical companies, and others. In terms of application, the global single-cell genome sequencing market is segmented into subpopulation characterization, circulating cells, genomic variation, cell differentiation and reprogramming, and others.
Global Single-Cell Genome Sequencing Market: Regional Analysis
North America is likely to be the most dominating and leading region for the global single-cell genome sequencing market coupled with the U.S. being the most important revenue contributor. Some aspects responsible for the domination of this province are growing immunological disorders, mounting cases of cancer, and neuropsychiatric diseases along with technological developments brought by entities operating in the province.
On the other hand, Asia Pacific is projected to emerge as the highest growing division due to rising R&D spending in the field. Furthermore, ample administration collaborations and support among entities particularly in Asian countries are also projected to propel the expansion of the regional market.
Global Single-Cell Genome Sequencing Market: Competitive Players
Some of the most important market players in the global single-cell genome sequencing market are F Hoffmann-La Roche Ltd., 10x Genomics, Bio-Rad Laboratories, Fluidigm, Novogene, Illumina, Inc., BGI, Pacific Biosciences, Oxford Nanopore Technologies, QIAGEN, and Thermo Fisher Scientific, Inc., among others.
Global Single-Cell Genome Sequencing Market: Regional Segment Analysis
What Reports Provides
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed